Boothbay Fund Management, LLC Zai Lab LTD Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $276,589 - $641,424	9,960 New	9,960 $438,000
Q2 2021 Aug 16, 2021	SELL	$125.11 - $180.0 $549,483 - $790,560	-4,392 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $554,577 - $841,990	4,392 New	4,392 $586,000
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $197,340 - $326,304	-13,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $234,960 - $334,620	13,200 New	13,200 $257,000

133

48.9M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.74B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.